SCHEMBL62193

SCHEMBL62193

O=C(O)c1[nH]c2ccccc2c1O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.62
ALDH1A1 P00352 4/20 0.62
HPGD P15428 2/20 0.62
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
POLB P06746 1/20 0.57
FOLH1 Q04609 1/20 0.56
MAPT P10636 3/20 0.55
IDE P14735 1/20 0.55
MPI P34949 1/20 0.55
CACNA1B Q00975 1/20 0.55
APBA1 Q02410 1/20 0.55
APP P05067 1/20 0.50
GAA P10253 1/20 0.50
GFER P55789 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAP2 P11137 1/20 0.50
MCL1 Q07820 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366683 1.00 KDM4E (0.62) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL30393982 0.87 KDM4E (0.57) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL756338 0.87 KDM4E (0.57) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL28197191 0.86 ALDH1A1 (0.57) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL5568381 0.82 KDM4E (0.53) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL30373749 0.82 KDM4E (0.53) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL61857 0.82 MAP2 (0.62) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL29897041 0.80 ALDH1A1 (0.63) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2399274 0.80 ALDH1A1 (0.63) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL87871 0.80 KDM4E (0.65) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110423212-B Hydroxy indole carboxylic acid-based inhibitors of SHP2 美国印第安纳大学研究和技术公司 2023-05-09 CN claimed
CN-105142634-B Oxindole carboxylic acid-based inhibitors of oncogenic protein tyrosine phosphatase-2(SHP2) comprising Src homology-2domain 美国印第安纳大学研究和技术公司 2020-06-12 CN claimed
US-9522881-B2 Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2016-12-20 US claimed
US-20160102054-A1 HYDROXYINDOLE CARBOXYLIC ACID BASED INHIBITORS FOR ONCOGENIC SRC HOMOLOGY-2 DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2) INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2016-04-14 US claimed
EP-2988741-A1 HYDROXYINDOLE CARBOXYLIC ACID BASED INHIBITORS FOR ONCOGENIC SRC HOMOLOGY-2 DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2) Indiana University Research&Technology Corporation (US) 2016-03-02 EP claimed
WO-2014176488-A1 HYDROXYINDOLE CARBOXYLIC ACID BASED INHIBITORS FOR ONCOGENIC SRC HOMOLOGY-2 DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2) INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2014-10-30 WO claimed
US-4459349-A A 2-NAPHTHYL-4,5-DIPHENYLIMIDAZOLYL DIMER, UNSATURATED MONOMER TOYO BOSEKI KABUSHIKI KAISHA (JP) 1984-07-10 US claimed
JP-58015531-A None JP disclosed
JP-58045210-A None JP disclosed
CN-110423212-B Hydroxy indole carboxylic acid-based inhibitors of SHP2 美国印第安纳大学研究和技术公司 2023-05-09 CN disclosed
CN-110423212-B Hydroxy indole carboxylic acid-based inhibitors of SHP2 美国印第安纳大学研究和技术公司 2023-05-09 CN disclosed
CN-110423212-B Hydroxy indole carboxylic acid-based inhibitors of SHP2 美国印第安纳大学研究和技术公司 2023-05-09 CN disclosed
US-20230034584-A1 INHIBITORS OF SHP2 BAYER AKTIENGESELLSCHAFT (DE) 2023-02-02 US disclosed
US-4110464-A INDOLOPYRONES HAVING ANTIALLERGIC ACTIVITY WARNER-LAMBERT COMPANY (US) 1978-08-29 US disclosed
US-4087443-A ANTIALLERGENS, ASTHMA WARNER-LAMBERT COMPANY (US) 1978-05-02 US disclosed
US-4066660-A INTERMEDIATES IN THE PREPARATION OF INDOLOBENZOXAZEPINES WARNER-LAMBERT COMPANY (US) 1978-01-03 US disclosed
US-4028383-A DIMETHYLSULFONE REACTED WITH AN ESTER OF A SUBSTITUTED INDOXYLIC ACID WARNER-LAMBERT COMPANY (US) 1977-06-07 US disclosed
US-4013641-A INDOLOBENZOXAZEPINES XEROX CORPORATION (US) 1977-03-22 US disclosed
US-3976635-A Novel esterifying agents, and their production and use FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-08-24 US disclosed
US-690332-A ACYLATED INDOXYLIC ACID AND PROCESS OF MAKING SAME. BASF AG (DE) 1901-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102054-A1 HYDROXYINDOLE CARBOXYLIC ACID BASED INHIBITORS FOR ONCOGENIC SRC HOMOLOGY-2 DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2) SRC, PTPRCAP, PTPRJ KDM4E 1178/4885ALDH1A1 2239/4885HPGD 2557/4885
US-20230034584-A1 INHIBITORS OF SHP2 PTPN1, PTPN2, PTPRJ KDM4E 842/4885ALDH1A1 3729/4885HPGD 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.